Survival Benefit of Compound Kushen Injection in the Treatment of Advanced Colorectal Cancer

To clarify the effectiveness and safety of compound kushen injection in the treatment of advanced colorectal cancer.

Trial Details

NCT ID
NCT05894694
Phase
PHASE4
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • first-line scheme+compound kushen injection
  • palliative care group first-line scheme
Locations (sample)
  • Beijing, China|39.9075,116.39723

Key Eligibility Criteria

  • ① Patients with advanced CRC confirmed by pathology or cytology and receiving first-line therapy;② Aged ≥ 18 years old, male or female;③ ECOG score…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →